All articles tagged with #rklb
An overnight snapshot of space-related equities shows Sidus Space (SIDU) leading gains with about a 21% rise, alongside a broad mix of movers across tech and space names. The data feed lists several other tickers with notable moves (including moments like MNTS and BRAI), illustrating a volatile session where some space-focused and growth stocks jump while others retreat across various exchanges.
Rocket Lab rose about 12% after a strong Q1 report that delivered a record revenue beat and a growing backlog, with momentum in the Neutron program cited as a key driver. Several analysts raised price targets (to as high as $120) whilekeeping Buy ratings, signaling bullish sentiment on RKLB’s launch services and space systems franchises. The stock has surged roughly 70% year-to-date and about 400% over the past year on the back of the beat and broader momentum.
Rocket Lab’s Q1 beat and optimistic outlook prompted Cowen and Needham to raise RKLB’s price target to a joint street-high of $120, underscoring robust demand for Electron and HASTE with 31 Electron/HASTE bookings and a $190 million HASTE order, plus 5 Neutron bookings and Neutron’s planned 4Q26 first launch. The Mynaric acquisition should expand European revenue opportunities, and SDA Tranche 3 revenue (~$82 million in 2026) adds to near-term growth, though margins may face pressure from mix. Despite a Moderate Buy consensus, the 96.25 average target sits about 9% below the current price, leaving room for potential upgrades or downgrades ahead.
Rocket Lab (RKLB) surged roughly 30% intraday after reporting Q1 FY2026 revenue of $200.35M (+64% YoY, beating estimates) and a backlog of $2.2B on 31 Electron/HASTE contracts and five Neutron missions, plus a Raytheon Space Based Interceptor win; Q2 revenue guidance is $225–$240M. Intuitive Machines (LUNR) rose about 21% on strong 2026 guidance and the Lanteris acquisition, while Planet Labs (PL) gained around 10% and leads YTD; by absolute intraday performance RKLB outpaced peers, though PL and LUNR remain ahead on the year. The space-equipment market remains sensitive to defense demand and upcoming catalysts like Neutron's debut, with some risk factors like insider stock sales by RKLB executives looming in assessing longer-term prospects.
Rocket Lab jumped ~26% after a blowout Q1: revenue $200.3M and gross profit $76.5M, beating expectations; Q2 revenue guidance of $225–$240M topped estimates, with a backlog near $2.2B and Neutron on track for late 2026. Strength across Launch and Space Systems and new contracts underpin growth, and Stifel’s Erik Rasmussen reiterated a Buy with a $110 target, citing high barriers to entry and limited competition as reasons for a long-term premium.
ARK Invest anchored X-Energy's Nasdaq debut by buying more than 4 million shares (~$92.5M) and boosted its Amazon stake by about 280,450 shares (~$71.5M) ahead of earnings, while trimming AMD by $65.8M and reducing Rocket Lab by $9.6M, signaling a tilt toward nuclear energy and Amazon while locking in gains on earlier winners.
SpaceX’s Falcon 9 mission delivering 29 Starlink satellites and booster landing spurred mixed moves in space stocks: RKLB +2.8%, ASTS +3.3%, LUNR −5.2%, SPCE −2.7%. Analysts show varied ratings across the group, with Intuitive Machines (LUNR) seen as the strongest buy and SPCE offering the largest upside. SpaceX remains private, with IPO chatter ongoing; TSLA is suggested as a potential proxy for investors until an IPO materializes.
Rocket Lab's revenue mix is moving toward defense-related programs, with Space Systems delivering a large portion of Q4 revenue and the backlog expanding to $1.85 billion. A delay of the Neutron program to late 2026 adds near-term execution risk, while the stock trades around 52x 2026 sales, reflecting lofty growth expectations as management targets revenue growth from roughly $850 million to about $3.7 billion over the next five years.
Rocket Lab (RKLB) stock slipped after Congress scrapped a plan to return NASA Mars Perseverance rover samples, a project Rocket Lab proposed handling by 2031 under a fixed-price contract; the setback matters less for near-term revenue but RKLB’s high valuation (~45x expected 2027 sales) makes it sensitive to headlines, with analysts still signaling a Moderate Buy and about 15% upside ahead of Artemis II.
Rocket Lab's stock soared 9.5% after successfully launching a mission for the U.S. Space Force ahead of schedule, demonstrating its reliability in national security launches. Despite recent volatility and profit-taking after a 141% year-to-date increase, the company's strong performance and technological achievements suggest potential for continued growth, though the stock remains below its 52-week high.
Rocket Lab (RKLB) has received a street-high price target amid comparisons to SpaceX, indicating strong investor confidence and positive outlook for the company's growth prospects.